Skip to Main Content

Paper Details

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.
Nature Communications
15
2021
CAR, CARs, Chimeric antigen receptor, Chimeric antigen receptor (CAR) T cells, HLA, HLA-B*07:02, IDH2, IDH2R140Q, R140Q, cancer, cancers, chimeric antigen receptors, human, human leukocyte antigen allele, isocitrate, isocitrate dehydrogenase 2, tumor
Author NameAffiliation
Chetan BettegowdaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Chetan BettegowdaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Chetan BettegowdaJohns Hopkins University School of Medicine
Chetan BettegowdaJohns Hopkins University School of Medicine
Nickolas PapadopoulosSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Nickolas PapadopoulosSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Nickolas PapadopoulosJohns Hopkins University School of Medicine
Nickolas PapadopoulosJohns Hopkins University School of Medicine
Nickolas PapadopoulosSol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine
Kenneth W KinzlerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Kenneth W KinzlerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Kenneth W KinzlerBloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center
Kenneth W KinzlerJohns Hopkins University School of Medicine
Kenneth W KinzlerSol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine
Bert VogelsteinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Bert VogelsteinHoward Hughes Medical Institute
Bert VogelsteinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Bert VogelsteinBloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center
Bert VogelsteinJohns Hopkins University School of Medicine
Bert VogelsteinJohns Hopkins University School of Medicine
Bert VogelsteinSol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine
  • 1 - 21

Datasets